Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 107Myelodysplastic Syndromes 100Leukemia, Myeloid, Acute 99Hodgkin Disease 81Leukemia, Lymphocytic, Chronic, B-Cell 78Lymphoma 76Lymphoma, Non-Hodgkin 75Leukemia 73Multiple Myeloma 64Lymphoma, Follicular 54Myeloproliferative Disorders 51Lymphoma, Mantle-Cell 50Lymphoma, Large B-Cell, Diffuse 50Lymphoma, B-Cell, Marginal Zone 44Leukemia, Myeloid, Accelerated Phase 44Congenital Abnormalities 42Burkitt Lymphoma 42Leukemia, Myelomonocytic, Chronic 41Leukemia, Myeloid, Chronic-Phase 40Graft vs Host Disease 39Leukemia, Myelogenous, Chronic, BCR-ABL Positive 38Primary Myelofibrosis 36Neoplasms, Plasma Cell 35Blast Crisis 35Lymphoma, Large-Cell, Immunoblastic 34Waldenstrom Macroglobulinemia 26Lymphoma, T-Cell, Cutaneous 23Sezary Syndrome 22Myelodysplastic-Myeloproliferative Diseases 22Mycosis Fungoides 22

Interventions

fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Methotrexate 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
GATA2 Deficiency × Tacrolimus × Lymphoid × Clear all
NCT03779854 2026-05-14

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Recruiting
68 enrolled
LymphoidMyeloidOther hematologic neoplasm

GATA2 Deficiency, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Leukemia, Mast-Cell, Leukemia, Myeloid, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡